797 related articles for article (PubMed ID: 37198232)
1. Targeting strategies for bone diseases: signaling pathways and clinical studies.
Xu H; Wang W; Liu X; Huang W; Zhu C; Xu Y; Yang H; Bai J; Geng D
Signal Transduct Target Ther; 2023 May; 8(1):202. PubMed ID: 37198232
[TBL] [Abstract][Full Text] [Related]
2. Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders.
Dang L; Liu J; Li F; Wang L; Li D; Guo B; He X; Jiang F; Liang C; Liu B; Badshah SA; He B; Lu J; Lu C; Lu A; Zhang G
Int J Mol Sci; 2016 Mar; 17(3):428. PubMed ID: 27011176
[TBL] [Abstract][Full Text] [Related]
3. Targeted Drug Delivery - From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives.
Tewabe A; Abate A; Tamrie M; Seyfu A; Abdela Siraj E
J Multidiscip Healthc; 2021; 14():1711-1724. PubMed ID: 34267523
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in bone-targeted therapy.
Shi C; Wu T; He Y; Zhang Y; Fu D
Pharmacol Ther; 2020 Mar; 207():107473. PubMed ID: 31926198
[TBL] [Abstract][Full Text] [Related]
5. The impact of molecular targets in cancer drug development: major hurdles and future strategies.
Hebar A; Valent P; Selzer E
Expert Rev Clin Pharmacol; 2013 Jan; 6(1):23-34. PubMed ID: 23272790
[TBL] [Abstract][Full Text] [Related]
6. Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.
Katsumi H; Yamashita S; Morishita M; Yamamoto A
Chem Pharm Bull (Tokyo); 2020; 68(7):560-566. PubMed ID: 32611993
[TBL] [Abstract][Full Text] [Related]
7. Bone-seeking agents for the treatment of bone disorders.
Cawthray J; Wasan E; Wasan K
Drug Deliv Transl Res; 2017 Aug; 7(4):466-481. PubMed ID: 28589453
[TBL] [Abstract][Full Text] [Related]
8. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
9. Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.
Hirabayashi H; Fujisaki J
Clin Pharmacokinet; 2003; 42(15):1319-30. PubMed ID: 14674786
[TBL] [Abstract][Full Text] [Related]
10. Designing proteins for bone targeting.
Gittens SA; Bansal G; Zernicke RF; Uludağ H
Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Non-Viral Delivery System and Targeted Bone Disease Therapy.
Qadir A; Gao Y; Suryaji P; Tian Y; Lin X; Dang K; Jiang S; Li Y; Miao Z; Qian A
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699924
[TBL] [Abstract][Full Text] [Related]
13. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
14. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.
Li CJ; Liu XZ; Zhang L; Chen LB; Shi X; Wu SJ; Zhao JN
Orthop Surg; 2016 May; 8(2):105-10. PubMed ID: 27384718
[TBL] [Abstract][Full Text] [Related]
15. Skeletal function and structure: implications for tissue-targeted therapeutics.
Shea JE; Miller SC
Adv Drug Deliv Rev; 2005 May; 57(7):945-57. PubMed ID: 15876397
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymers: an update on drug delivery in bone and cartilage diseases.
Lima AC; Ferreira H; Reis RL; Neves NM
Expert Opin Drug Deliv; 2019 Aug; 16(8):795-813. PubMed ID: 31220958
[No Abstract] [Full Text] [Related]
17. Molecular platforms for targeted drug delivery.
Maso K; Grigoletto A; Vicent MJ; Pasut G
Int Rev Cell Mol Biol; 2019; 346():1-50. PubMed ID: 31122392
[TBL] [Abstract][Full Text] [Related]
18. Denosumab for bone diseases: translating bone biology into targeted therapy.
Tsourdi E; Rachner TD; Rauner M; Hamann C; Hofbauer LC
Eur J Endocrinol; 2011 Dec; 165(6):833-40. PubMed ID: 21852390
[TBL] [Abstract][Full Text] [Related]
19. The ligand nanoparticle conjugation approach for targeted cancer therapy.
Karra N; Benita S
Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
